ArticleTranslational pediatrics2025
The acid-base balance homeostasis reflected by urine pH in children with infantile epileptic spasm syndrome may be associated with response to adrenocorticotropic hormone treatment: a retrospective cohort study.
Article in Translational pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Infantile epileptic spasms syndrome (IESS) is an age-related developmental and epileptic encephalopathy. Adrenocorticotropic hormone (ACTH), one of the first-line treatment, has its efficacy influenced by multiple factors. This study aimed to investigate and analyze clinical variables (pre-treatment clinical data, serum and urine routine test) in children with IESS to predict outcomes after the first ACTH treatment. Furthermore, the potential impact of underlying factors on ACTH efficacy was assessed. Methods: A total of 186 children who received ACTH treatment for the first time in the Pediatric Department of The First Medical Center of the Chinese PLA General Hospital from January 2018 to June 2023 were retrospectively evaluated. They were divided into the responsive group and the non-responsive group according to the clinical outcomes after treatment. The clinical data of the two groups were compared, followed by logistic regression analysis to evaluate the relationship between the factors and ACTH treatment outcome. Results: The lead time between the first spasm onset and ACTH treatment initiation was significantly shorter in the responsive group compared with the non-responsive group. Additionally, more patients experienced epileptic spasms after the age of 3 months and responded significantly better to ACTH treatment than those whose spasms began within the first 3 months. Compared to children with IESS of unknown etiology, patients with congenital genetic abnormalities without structural abnormalities were less likely to have a short-term response to ACTH treatment. Despite no significant differences in serum sodium, potassium, calcium, and chloride levels between the two groups, pre-treatment serum inorganic phosphate levels were correlated with ACTH efficacy. The responsive group had significantly higher pre-treatment urinary pH levels. Conclusions: IESS patients should receive first-line treatment immediately after spasm onset. The age of epileptic spasms onset and its etiology may help predict the efficacy of ACTH treatment. Serum inorganic phosphate levels and urinary pH levels seem to play an important role in the treatment of IESS with ACTH, and they may have indicative significance for precision treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.